KIGALI, July 17 (Xinhua) -- Health experts are calling on governments around the world to increase funding for HIV research and community-led responses, warning that current funding cuts risk ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

The US Senate has moved to spare the world’s biggest HIV treatment and prevention programme – which funds drugs and research in more than 50 countries – from $400m (£298m) of aid cuts imposed by ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

However, despite the Senate's decision to protect Pepfar from President Trump's proposed $400 million (Sh51.6 billion) ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

The International AIDS Society (IAS) has praised a bipartisan effort by the United States Senate to shield the President’s ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...